Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).
about
Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniquesDC-STAMP: A Key Regulator in Osteoclast DifferentiationStrawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMPOsteoclast fusion is based on heterogeneity between fusion partnersOsteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.Enoxacin directly inhibits osteoclastogenesis without inducing apoptosisBromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways.Osteoclast fusion and regulation by RANKL-dependent and independent factors.Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis.Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclastsProduction of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.Horizontal alignment of 5' -> 3' intergene distance segment tropy with respect to the gene as the conserved basis for DNA transcription.The IL-23/IL-17 axis in psoriatic arthritis.Osteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodelingOsteoclast differentiation inhibitors: a patent review (2008 - 2012).DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis.Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.Biomarkers in psoriatic arthritis: recent progress.Alternative pathways of osteoclastogenesis in inflammatory arthritis.Muscle Paralysis Induces Bone Marrow Inflammation and Predisposition to Formation of Giant Osteoclasts.A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.Emerging biomarkers in psoriatic arthritis.Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss.Osteoclast Fusion: Time-Lapse Reveals Involvement of CD47 and Syncytin-1 at Different Stages of Nuclearity.DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP.Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis.Monocyte Subsets Have Distinct Patterns of Tetraspanin Expression and Different Capacities to Form Multinucleate Giant Cells.
P2860
Q27006383-ED68ED9C-74B6-406E-8B0F-E62B24EA2ED8Q28079466-BE77EA87-C672-4FF5-AC4F-C962729A11AFQ28586492-60103195-2519-4F7D-A430-9935C3D4F518Q33723296-18538506-1D65-45BA-BA22-4996138EB94DQ33771321-9BB7997B-DE0C-4F62-8224-320CEB652F48Q34545263-41C81DD5-2B71-4008-AF93-ACBE0498031DQ34950497-06656F50-A41E-4994-8023-2FAE3177C9E1Q36003737-DEE5B44D-C1E7-4BC5-BC44-E6FF722D075DQ36006859-0E295881-E454-40E2-AD9C-87A700088E85Q36385001-8CC54936-47B4-43B9-9725-5B3BBEC0F0D1Q36568536-F6785093-C8AA-4290-8B3E-00BB81517EA9Q36579296-840CA74B-A71B-4E35-AC61-B1E8695DEC6BQ36583285-47388E6D-965D-4440-A99D-D8E3FBC4080DQ36733053-233A5DF3-3F52-4707-BEBA-A75B8967785DQ37115802-03768CA6-0C7F-4E41-8A4E-0EED5D6AB680Q37701762-1BC2027A-CE3A-469C-9272-E795D6241252Q37717133-55A4DBCB-5E55-401A-94A2-A502B003F2A5Q38116019-D17C23A0-E714-49C3-9A71-21579DC7D560Q38149300-6909536F-54FB-4735-9D20-AE4DF751BB83Q38178193-FED83F05-370D-4398-962F-B19D47AA6DC0Q38218977-29493C9D-59BD-48C2-9FC4-0544F7C7DA8CQ38248904-B2A49E0C-8454-4B68-9BD9-EA727EBCFC40Q38271156-5995D70D-3A09-40F8-A493-077F0DD1E088Q38601750-5EB643AE-3C02-48A6-ABBB-3734BC2ABE90Q38634916-1B2627F0-E296-4207-8FE1-64B4444696E5Q38646234-8C70ACB0-24C0-4111-AB1F-AD784E1A3D23Q38675617-01AF8B4E-ACBF-4AB8-B9E6-E823848E4E7AQ39313615-C39DBBD6-5D65-42AA-BE5C-0C7045A96F69Q40332532-0502743D-D0F5-42B3-8290-7A9853D03549Q44166987-FEB05B09-6361-4D43-8B46-A8AF91791F6DQ50882156-7F234EFD-EBEC-463F-BDB1-F1FD22AFBBFCQ51141211-7B901E4C-BC12-40F3-AD1C-83C027C97B85Q55437304-F860C7C6-FD87-479D-93A0-093583A2BC96
P2860
Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@ast
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@en
Regulation of human osteoclast ...... specific transmembrane protein
@nl
type
label
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@ast
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@en
Regulation of human osteoclast ...... specific transmembrane protein
@nl
prefLabel
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@ast
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@en
Regulation of human osteoclast ...... specific transmembrane protein
@nl
P2093
P2860
P356
P1476
Regulation of human osteoclast ...... nsmembrane protein (DC-STAMP).
@en
P2093
Ben Panepento
Changyong Feng
Christopher T Ritchlin
David G Hicks
Edward M Schwarz
Kofi A Mensah
Loralee A McMahon
Masahiko Takahata
Peter C Keng
Ya-Hui Chiu
P2860
P356
10.1002/JBMR.531
P577
2012-01-01T00:00:00Z